Macquarie Has Lowered Expectations for Surgery Partners (NASDAQ:SGRY) Stock Price

Surgery Partners (NASDAQ:SGRY) had its target price trimmed by Macquarie from $35.00 to $34.00 in a research report report published on Wednesday,Benzinga reports. The firm currently has an outperform rating on the stock.

Other equities analysts have also issued research reports about the stock. Royal Bank of Canada restated an “outperform” rating and set a $49.00 target price on shares of Surgery Partners in a research report on Wednesday, August 7th. Cantor Fitzgerald reiterated an “overweight” rating and set a $43.00 price objective on shares of Surgery Partners in a research report on Friday, October 4th. Benchmark reiterated a “buy” rating and set a $50.00 price objective on shares of Surgery Partners in a research report on Monday, August 26th. StockNews.com lowered shares of Surgery Partners from a “hold” rating to a “sell” rating in a research report on Wednesday, August 7th. Finally, KeyCorp started coverage on shares of Surgery Partners in a research report on Friday, October 11th. They set a “sector weight” rating for the company. One research analyst has rated the stock with a sell rating, two have given a hold rating and six have issued a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $40.71.

Surgery Partners Price Performance

Shares of NASDAQ:SGRY opened at $22.95 on Wednesday. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.69 and a current ratio of 1.80. The firm has a fifty day moving average price of $30.62 and a 200 day moving average price of $28.43. Surgery Partners has a fifty-two week low of $22.25 and a fifty-two week high of $36.92. The firm has a market cap of $2.92 billion, a price-to-earnings ratio of -47.81, a P/E/G ratio of 18.74 and a beta of 2.76.

Institutional Investors Weigh In On Surgery Partners

Institutional investors have recently made changes to their positions in the company. First Eagle Investment Management LLC lifted its holdings in shares of Surgery Partners by 16.5% in the 1st quarter. First Eagle Investment Management LLC now owns 339,474 shares of the company’s stock worth $10,127,000 after acquiring an additional 48,100 shares during the last quarter. Bamco Inc. NY increased its stake in Surgery Partners by 100.0% in the 1st quarter. Bamco Inc. NY now owns 90,000 shares of the company’s stock worth $2,685,000 after buying an additional 45,000 shares during the period. Lombard Odier Asset Management Europe Ltd purchased a new position in Surgery Partners in the 2nd quarter worth about $4,163,000. Rhumbline Advisers increased its stake in Surgery Partners by 19.6% in the 2nd quarter. Rhumbline Advisers now owns 127,952 shares of the company’s stock worth $3,044,000 after buying an additional 20,963 shares during the period. Finally, Janus Henderson Group PLC increased its stake in Surgery Partners by 7,987.1% in the 1st quarter. Janus Henderson Group PLC now owns 2,504,248 shares of the company’s stock worth $74,701,000 after buying an additional 2,473,282 shares during the period.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.